Aptahem AB (XSAT:APTA) Moat Score: 0/10 (As of Jul. 07, 2026)


XSAT:APTA Aptahem AB XSAT:APTA
30 GF Score
Price kr0.60
! 2 Warning Signs
View Full Analysis

What is Aptahem AB Moat Score?

Aptahem AB has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Aptahem AB has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Aptahem AB might have No Moat - No discernible moat.

Aptahem AB  (XSAT:APTA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Aptahem AB Moat Score Related Terms

XSAT:APTA
30GF Score
Aptahem AB XSAT:APTA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptahem AB Business Description

Address Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
30GF Score

Get the complete analysis for XSAT:APTA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.60
Price